Abstract:Chiral benzoins are versatile precursors to various valuable synthons such as chiral hydrobenzoins and chiral vicinal amino alcohols. In principle, ketoreductase (KRED)-catalyzed asymmetric reduction of benzils could be one of the most straightforward, green, and stereoselective methods for the synthesis of chiral benzoins. Nevertheless, the practical application potential of this appealing approach has been hampered by the low substrate loadings (usually <10 g/L) and unsatisfactory catalytic efficiency reported to date. In the present work, through enzyme screening, wild-type (WT) ketoreductase SSCR was revealed to possess a decent specific activity of 69.8 U/mg against the unsubstituted benzil molecule 1a. Aided by structure-guided semirational protein engineering including alanine-scanning and site-saturation mutagenesis, SSCRQ245G, a variant of SSCR, was evolved with 5.0-fold improvement in specific activity (350.5 U/mg) and 7.0-fold enhancement in catalytic efficiency (1131 s(-1)mM(-1)), compared with the WT. By using SSCRQ245G as the reductase and employing glucose dehydrogenase (GDH) for the regeneration of nicotinamide adenine dinucleotide phosphate (NADPH), gratifyingly, as high as 100 g/L of 1a was completely reduced in a 5-gram-scale reaction, with the desired benzoin (S)-2a obtained in 96% isolated yield with 99% ee. Our developed biocatalytic synthesis also features a good space-time yield of 233 gL-1day(-1) and a decent E-factor of 44 (including water). Moreover, a three-step transformation of such biosynthesized benzoin (S)-2a into a synthetically useful chiral vicinal amino alcohol ligand 5 was realized in 64% overall yield. Finally, the synthetic potential of SSCRQ245G was further underscored by the smooth reduction of 16 other symmetrical and unsymmetrical benzils, delivering the corresponding chiral benzoins in 57-93% isolated yields with mostly good-to-excellent stereoselectivities (up to >99% ee). The current study not only provides efficient and sustainable access to chiral benzoins but also highlights the synthetic versatility of engineered ketoreductase-catalyzed stereoselective reduction of prochiral ketones.

Efficient synthesis of a chiral precursor for angiotensin-converting enzyme (ACE) inhibitors in high space-time yield by a new reductase without external cofactors.

Redesign of a Short-Chain Dehydrogenase/reductase for Asymmetric Synthesis of Ethyl (R)-2-hydroxy-4-phenylbutanoate Based on Per-Residue Free Energy Decomposition and Sequence Conservatism Analysis

Highly efficient synthesis of the chiral ACE inhibitor intermediate (R)-2-hydroxy-4-phenylbutyrate ethyl ester via engineered bi-enzyme coupled systems

Semi-rational Design of Carbonyl Reductase Cat for Synthesis of (R)-Lipoic Acid Precursor

Development of an Engineered Ketoreductase with Improved Activity, Stereoselectivity and Relieved Substrate Inhibition for Enantioselective Synthesis of a Key (R)-Α-lipoic Acid Precursor

Biocatalytic anti-Prelog reduction of prochiral ketones with whole cells of a newly isolated strain Empedobacter brevis ZJUY-1401

Asymmetric Synthesis of Chiral Benzoins Enabled by Engineered Ketoreductase-Catalyzed Stereoselective Reduction of Benzils

Discovery and Engineering of an Ene‐reductase for Kinetic Resolution and Cascade Reduction of Hajos–Parrish/Wieland–Miescher Ketones

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

Rational Design of Dehydrogenase/Reductases Based on Comparative Structural Analysis of Prereaction-State and Free-State Simulations for Efficient Asymmetric Reduction of Bulky Aryl Ketones

Sustainable Asymmetric Synthesis of Diltiazem Precursor Enabled by Recombinant Escherichia coli Whole Cells Co‐Expressing an Engineered Ketoreductase and Glucose Dehydrogenase

Asymmetric Reduction of Ethyl 4-Chloroacetoacetate to Ethyl (R)-(+)-4-chloro-3-hydroxybutyrate by Recombinant Escherichia Coli

Enantio‐ and Diastereoselective Synthesis of Chiral Syn ‐Aryl β‐Hydroxy α‐Amino Esters via Biocatalytic Dynamic Reductive Kinetic Resolution

Ene-Reductase-Catalyzed Enantioselective Desymmetrization of Cyclohexadienones: Straightforward Access to All-Carbon Quaternary Stereocenters

Rational design of the carbonyl reductase EbSDR8 for efficient biosynthesis of enantiopure (R)-3-chloro-1-phenyl-1-propanol

Biocatalytic Asymmetric Reduction of a Sterically Hindered α-Bromo Ketone for the Synthesis of Key Intermediates of Olodaterol

Asymmetric Synthesis of Both Enantiomers of Dimethyl 2-Methylsuccinate by the Ene-Reductase-Catalyzed Reduction at High Substrate Concentration

Highly efficient synthesis of rosuvastatin intermediate using a carbonyl reductase–cofactor co‐immobilized biocatalyst in the non‐aqueous biosystem

Combining Rh-Catalyzed Diazocoupling and Enzymatic Reduction to Efficiently Synthesize Enantioenriched 2-Substituted Succinate Derivatives

Access to chiral α-substituted-β-hydroxy arylphosphonates enabled by biocatalytic dynamic reductive kinetic resolution